Safety assessment and feasibility of the TWIICE powered exoskeleton for assisted ambulation in individuals with spinal cord injury.

ABSTRACT:

Background

Following spinal cord injury (SCI), powered exoskeletons have been shown to enable assisted walking and may also positively impact secondary health conditions. The TWIICE exoskeleton is intended to enable individuals with SCI to train at home or in community during their activities of daily living under the supervision of a therapist. The aim of this pilot clinical trial was to assess the safety and feasibility of the TWIICE powered exoskeleton for assisted ambulation in a clinical setting.

Methods

This single-arm, open label feasibility study included 5 non-ambulatory individuals at least 6 months after onset of traumatic or non-traumatic SCI. Participants used the TWIICE exoskeleton during 6 sessions in the therapy premises of a Swiss SCI-specialized clinic unde

SUBMITTER: Lang C 

PROVIDER: S-EPMC12465450 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature